Sorry, this section is only available in Japanese.
前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:202002220712630434   整理番号:20A1181197

肺食細胞由来NPYは重症インフルエンザウイルス感染の病理を制御する【JST・京大機械翻訳】

Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection
著者 (26件):
Fujiwara Seiki
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Hoshizaki Midori
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Ichida Yu
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Lex Dennis
(Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University, Aachen, Germany)
Kuroda Etsushi
(Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Kuroda Etsushi
(Laboratory of Vaccine Science, World Premier International Immunology Frontier Research Center, Osaka, Japan)
Ishii Ken J.
(Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Ishii Ken J.
(Laboratory of Vaccine Science, World Premier International Immunology Frontier Research Center, Osaka, Japan)
Magi Shigeyuki
(Laboratory of Cell Systems, Institute for Protein Research, Osaka University, Osaka, Japan)
Okada Mariko
(Laboratory of Cell Systems, Institute for Protein Research, Osaka University, Osaka, Japan)
Okada Mariko
(Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan)
Takao Hiroyuki
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Gandou Masahiro
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Imai Hirotaka
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Hara Ryujiro
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Herzog Herbert
(Neuroscience Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia)
Yoshimura Akihiko
(Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan)
Okamura Hitoshi
(Laboratory of Molecular Brain Science, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)
Penninger Josef M.
(Institute of Molecular Biotechnology in the Austrian Academy of Sciences, Vienna, Austria)
Penninger Josef M.
(Life Science Institute, University of British Columbia, Vancouver, Canada)
Slutsky Arthur S.
(Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada)
Slutsky Arthur S.
(Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada)
Uhlig Stefan
(Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University, Aachen, Germany)
Kuba Keiji
(Department of Biochemistry and Metabolic Science, Akita University Graduate School of Medicine, Akita, Japan)
Imai Yumiko
(Laboratory of Regulation for Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), Osaka, Japan)
Imai Yumiko
(Laboratory of Infection Systems, Institute for Protein Research, Osaka University, Osaka, Japan)

資料名:
Nature Microbiology  (Nature Microbiology)

巻:号:ページ: 258-268  発行年: 2019年 
JST資料番号: W4779A  ISSN: 2058-5276  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: ドイツ (DEU)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。